The Pitt's strong Emmy campaign and multiple supporting actor nominations have positioned Patrick Ball as the narrow frontrunner at 47.5% implied probability, bolstered by the medical drama's dominant 25 total nods and critical momentum for his role as Dr. Frank Langdon. Tom Pelphrey sits at 33% on the strength of his acclaimed turn in Task, where guild and critics' attention has kept him competitive despite the HBO series' more limited overall buzz. Shawn Hatosy's 14.6% reflects solid Pitt ensemble support but highlights potential vote-splitting risks among the show's three contenders. Lower probabilities for Jack Lowden, Billy Crudup, and others align with weaker precursor signals and historical patterns favoring breakout performances from buzzy new dramas ahead of the September ceremony.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourEmmys 2026 : Acteur de soutien exceptionnel dans une série dramatique
Patrick Ball – « The Pitt » 48%
Tom Pelphrey – « Task » 33%
Shawn Hatosy – « The Pitt » 14.7%
Jack Lowden – « Slow Horses » 5.0%
$26,235 Vol.
$26,235 Vol.
Patrick Ball – « The Pitt »
48%
Tom Pelphrey – « Task »
33%
Shawn Hatosy – « The Pitt »
15%
Jack Lowden – « Slow Horses »
5%
Billy Crudup – « The Morning Show »
4%
Carlos-Manuel Vesga – « Pluribus »
2%
Gerran Howell – « The Pitt »
1%
Patrick Ball – « The Pitt » 48%
Tom Pelphrey – « Task » 33%
Shawn Hatosy – « The Pitt » 14.7%
Jack Lowden – « Slow Horses » 5.0%
$26,235 Vol.
$26,235 Vol.
Patrick Ball – « The Pitt »
48%
Tom Pelphrey – « Task »
33%
Shawn Hatosy – « The Pitt »
15%
Jack Lowden – « Slow Horses »
5%
Billy Crudup – « The Morning Show »
4%
Carlos-Manuel Vesga – « Pluribus »
2%
Gerran Howell – « The Pitt »
1%
This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding supporting actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Marché ouvert : Jul 9, 2026, 9:05 PM ET
Resolver
0x69c47De9D...This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding supporting actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...The Pitt's strong Emmy campaign and multiple supporting actor nominations have positioned Patrick Ball as the narrow frontrunner at 47.5% implied probability, bolstered by the medical drama's dominant 25 total nods and critical momentum for his role as Dr. Frank Langdon. Tom Pelphrey sits at 33% on the strength of his acclaimed turn in Task, where guild and critics' attention has kept him competitive despite the HBO series' more limited overall buzz. Shawn Hatosy's 14.6% reflects solid Pitt ensemble support but highlights potential vote-splitting risks among the show's three contenders. Lower probabilities for Jack Lowden, Billy Crudup, and others align with weaker precursor signals and historical patterns favoring breakout performances from buzzy new dramas ahead of the September ceremony.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes